SARS-CoV-2 Variants: Clinical, Vaccine, and Public Health Implications
We hope you enjoy this next instalment in our event summaries that we are preparing on a selection of our previous Speaker Series events. Each summary provides the reader with the presentation’s objective, what we heard as the key messages, next steps, and a link to the event’s recording. While this event series is conducted in English, these summaries have been translated into French.
Speakers
C Kaushic
Objective
To summarize the Speaker Series presentation led by Dr. Kaushic on ‘SARS-CoV-2 Variants: Clinical, Vaccine, and Public Health Implications.’ This presentation was held on February 9, 2021. The aim of her talk was to provide attendees with an overview of the information regarding the SARS-CoV-2 variants and emerging evidence on the effect of variants on public health, clinical outcomes, and vaccines efficacy.
Related Resources
Event
June 1, 2021
Evidence-Based Debunking: Needed and Effective
Speaker: T Caulfield
Event
May 27, 2021
Managing the Infodemic for Public Health: A Call to Action for an Evidence-Based Approach
Speaker: C Czerniak
Event
May 11, 2021
Improving Public Confidence in Science: Plain Language Recs on COVID‑19 Recommendations & Contextualization RecMap
Speakers: H Schünemann, K Pottie
Event
April 27, 2021
CoVaRR Net – Canada’s latest research network on the pandemic response
Speaker: M Langlois
